Views & Analysis Cost concerns with the new NHS pricing scheme A new pricing scheme, which took effect this month, has raised the cap on NHS spending on branded drugs slightly.
News Gazyva is first FDA-cleared drug for rare disease pMN Patients in the US with primary membranous nephropathy have a first approved drug, after the FDA cleared Roche's Gazyva for the rare kidney disorder.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.